麦迪科技上半年实现扭亏为盈 全面完成重症软件国产化适配与信创改造

Core Viewpoint - Suzhou Mediston Medical Technology Co., Ltd. (referred to as "Mediston") reported a significant turnaround in its financial performance for the first half of 2025, achieving a net profit of 28.33 million yuan, compared to a loss in the same period last year [1] Financial Performance - The company achieved operating revenue of 135 million yuan and a total profit of 31.14 million yuan during the reporting period [1] - The net profit attributable to shareholders was 28.33 million yuan, marking a return to profitability compared to the previous year [1] Technological Advancements - Mediston completed the domestic software localization and innovation transformation, ensuring compatibility with major domestic hardware and software platforms, meeting national technology requirements [1] - The products are now compatible with Huawei's Kunpeng series servers and support various domestic operating systems, including Tongxin UOS and Kylin [1] - The company has optimized its database compatibility with major domestic databases, ensuring efficient and stable operation in a secure environment [1] AI and Product Development - The company upgraded its anesthesia, critical care, and emergency systems with AI integration and deep fusion with the DeepSeek model [1] - The intelligent doctor assistant module provides clinical decision support, helping doctors formulate precise treatment plans based on patient history and examination data [1] Strategic Collaborations - Mediston's health and wellness robot project has initiated strategic collaborations with multiple medical institutions, focusing on the application of embodied intelligent robots in the health and elderly care sectors [2]